Novo Nordisk is a healthcare company and a world leader in diabetes care. Novo Nordisk also has a leading position within haemostasis management; growth hormone therapy and hormone replacement therapy.

Novo Nordisk employs more than 27 000 employees in 81 countries, and markets its products in 179 countries.